ACOUSORT AB

Company Snapshot

Founded: 2010
Entity Type: Public
Employees: 16
Revenue: $0.9 Millions
Revenue Year: 2024
Headquarter: Sweden
Key Geographics: Europe, Asia
Corporate Address: Medicon Village 223 81 Lund Sweden Tel. +46-70-787-7061 www.acousort.com

Company Overview

AcouSort is a medical technology Company developing critical components for instrumentation used in the diagnostics, analytics, and cell therapy processing markets. It offers integrated solutions for automated preparation of biological samples and standalone products for research purposes and technology evaluation/application development. AcouSort’s core technology is acoustofluidics, a combination of sound waves and microfluidics.  Acoustofluidics allows researchers/ clinicians to separate blood into its different constituents, isolate, enrich and purify cells and EVs including exosomes and perform rapid biochemical reactions on samples of cells or extracellular vesicles.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
Operating Income: ***

This information is available for BCC Research members only.

ACOUSORT AB In Reports

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

BCC Research Market Report provides an overview of Exosome Diagnostics and Therapeutics Market scope of the study is global. Current and projected market forecasts during the forecast period (2023 to 2028).

Company's Business Segments

  • Medical Technology : The company provides advanced medical technology to develop critical components utilized in analytics, diagnostics, and cell therapy processing markets.

Applications/End User Industries

  • Life Sciences
  • Healthcare
AI Sentiment